APA (7th ed.) Citation

Bourebaba, L., Serwotka-Suszczak, A., Bourebaba, N., Zyzak, M., & Marycz, K. The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity. Wiley.

Chicago Style (17th ed.) Citation

Bourebaba, Lynda, Anna Serwotka-Suszczak, Nabila Bourebaba, Magdalena Zyzak, and Krzysztof Marycz. The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver Through Anti-Inflammatory and Antifibrotic Activity. Wiley.

MLA (9th ed.) Citation

Bourebaba, Lynda, et al. The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver Through Anti-Inflammatory and Antifibrotic Activity. Wiley.